Literature DB >> 30057346

Deterioration rates in Virtual Reality Therapy: An individual patient data level meta-analysis.

Javier Fernández-Álvarez1, Alexander Rozental2, Per Carlbring3, Desirée Colombo4, Giuseppe Riva5, Page L Anderson6, Rosa María Baños7, Amanda A Benbow6, Stéphane Bouchard8, Juana María Bretón-López9, Georgina Cárdenas10, JoAnn Difede11, Paul Emmelkamp12, Azucena García-Palacios9, Verónica Guillén7, Hunter Hoffman13, Isabel Kampann12, Ramona Moldovan14, Andreas Mühlberger15, Max North16, Paul Pauli17, Wenceslao Peñate Castro18, Soledad Quero9, Miquel Tortella-Feliu19, Kataryzna Wyka11, Cristina Botella9.   

Abstract

Ample evidence supports the use of Virtual Reality (VR) for anxiety disorders. Nonetheless, currently there is no evidence about moderators or potential negative effects of VR treatment strategies. An Individual Patient Data (IPD) approach was employed with 15 retrieved datasets. The current study sample was composed of 810 patients. Randomized control trials (RCTs) for each primary outcome measure were performed, in addition to moderator analyses of the socio-demographic variables. Deterioration rates were 14 patients (4.0%) in VR, 8 (2.8%) in active control conditions, and 27 (15%) in the WL condition. With regard to receiving treatment, patients in a waiting list control condition had greater odds of deteriorating than in the two active conditions, odds ratios (ORs) 4.87, 95% confidence interval (CI) [0.05, 0.67]. In the case of the socio-demographic variables, none of them were associated with higher or lower odds of deterioration, with the exception of marital status in the WL condition; married people presented a significantly lower probability of deterioration, OR 0.19, 95% CI [0.05, 0.67]. Finally, when comparing pooled effects of VR versus all control conditions, the OR was 0.61 (95% CI 0.31-1.23) in favor of VR, although this result was not statistically significant. This study provides evidence about the deterioration rates of a therapeutic VR approach, showing that the number of deteriorated patients coincides with other therapeutic approaches, and that deterioration is less likely to occur, compared to patients in WL control groups.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety disorders; Deterioration rates; Individual patient data analysis; Virtual reality

Mesh:

Year:  2018        PMID: 30057346     DOI: 10.1016/j.janxdis.2018.06.005

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  15 in total

1.  Effectiveness of Self-guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Clinical Trial.

Authors:  Tara Donker; Ilja Cornelisz; Chris van Klaveren; Annemieke van Straten; Per Carlbring; Pim Cuijpers; Jean-Louis van Gelder
Journal:  JAMA Psychiatry       Date:  2019-07-01       Impact factor: 21.596

2.  Pilot randomized trial of self-guided virtual reality exposure therapy for social anxiety disorder.

Authors:  Nur Hani Zainal; William W Chan; Alisha P Saxena; Craig Barr Taylor; Michelle G Newman
Journal:  Behav Res Ther       Date:  2021-10-06

3.  Bringing Virtual Reality From Clinical Trials to Clinical Practice for the Treatment of Eating Disorders: An Example Using Virtual Reality Cue Exposure Therapy.

Authors:  Theresa Brown; Emily Nauman Vogel; Debra L Safer; Cristin D Runfola; Sarah Adler; Cara Bohon; Kim Bullock; Katherine Nameth; Giuseppe Riva
Journal:  J Med Internet Res       Date:  2020-04-23       Impact factor: 5.428

4.  Exposure to a Standardized Catastrophic Scenario in Virtual Reality or a Personalized Scenario in Imagination for Generalized Anxiety Disorder.

Authors:  Tanya Guitard; Stéphane Bouchard; Claude Bélanger; Maxine Berthiaume
Journal:  J Clin Med       Date:  2019-03-05       Impact factor: 4.241

Review 5.  Virtual Reality Therapy in Social Anxiety Disorder.

Authors:  Paul M G Emmelkamp; Katharina Meyerbröker; Nexhmedin Morina
Journal:  Curr Psychiatry Rep       Date:  2020-05-13       Impact factor: 5.285

6.  The Equivalence between Virtual and Real Feared Stimuli in a Phobic Adult Sample: A Neuroimaging Study.

Authors:  Wenceslao Peñate; Francisco Rivero; Conrado Viña; Manuel Herrero; Moisés Betancort; Juan De la Fuente; Yolanda Álvarez-Pérez; Ascensión Fumero
Journal:  J Clin Med       Date:  2019-12-04       Impact factor: 4.241

7.  Is Continued Improvement After Automated Virtual Reality Exposure Therapy for Spider Phobia Explained by Subsequent in-vivo Exposure? A First Test of the Lowered Threshold Hypothesis.

Authors:  Philip Lindner; Peter Dafgård; Alexander Miloff; Gerhard Andersson; Lena Reuterskiöld; William Hamilton; Per Carlbring
Journal:  Front Psychiatry       Date:  2021-05-20       Impact factor: 4.157

Review 8.  The Adoption of New Treatment Modalities by Health Professionals and the Relative Weight of Empirical Evidence in Favor of Virtual Reality Exposure Versus Mindfulness in the Treatment of Anxiety Disorders.

Authors:  Kevin Nolet; Giulia Corno; Stéphane Bouchard
Journal:  Front Hum Neurosci       Date:  2020-03-25       Impact factor: 3.169

9.  Gamified, Automated Virtual Reality Exposure Therapy for Fear of Spiders: A Single-Subject Trial Under Simulated Real-World Conditions.

Authors:  Philip Lindner; Alexander Miloff; Camilla Bergman; Gerhard Andersson; William Hamilton; Per Carlbring
Journal:  Front Psychiatry       Date:  2020-03-03       Impact factor: 4.157

10.  Evidence on Virtual Reality-Based Therapies for Psychiatric Disorders: Meta-Review of Meta-Analyses.

Authors:  Laura Dellazizzo; Stéphane Potvin; Mimosa Luigi; Alexandre Dumais
Journal:  J Med Internet Res       Date:  2020-08-19       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.